Phosphodiesterase inhibitors
Showing 1 - 25 of 4,463
IBD Trial (Pentoxifylline 400 MG)
Not yet recruiting
- Inflammatory Bowel Diseases
- Pentoxifylline 400 MG
- (no location specified)
Oct 28, 2022
Erectile Dysfunction Following Radiation Therapy, Phosphodiesterase Inhibitor Adverse Reaction, Platelet- Rich Plasma (PRP)
Active, not recruiting
- Erectile Dysfunction Following Radiation Therapy
- +2 more
- P shot arm ( Autologous Platelet Rich Plasma)
- PDE5i arm
-
Mansoura, Outside U.S./Canada, EgyptMansoura urology and nephrology center
Mar 15, 2023
Behçet's Disease Trial in Beijing (Hemay005, Placebo)
Recruiting
- Behçet's Disease
- Hemay005
- Placebo
-
Beijing, Beijing, ChinaPeking University People's Hospital
Nov 17, 2023
Carotid Artery Intima Media Thickness Can Predict Response to
Completed
- Erectile Dysfunction Due to Arterial Disease
- CIMT (Carotid artery intima media thickness measurement)
-
Bursa, TurkeyBursa Yuksek Ihtisas Training and Research Hospital
Jan 11, 2023
Benign Prostatic Hyperplasia Trial (Phosphodiesterase 5 Inhibitors, Alpha Blockers, Combined Alpha Blockers and
Not yet recruiting
- Benign Prostatic Hyperplasia
- Phosphodiesterase 5 Inhibitors
- +2 more
- (no location specified)
Feb 10, 2022
Single-ventricle, Pulmonary Hypertension, Univentricular Heart Trial (Sildenafil, Placebos)
Not yet recruiting
- Single-ventricle
- +2 more
- Sildenafil
- Placebos
- (no location specified)
Jan 20, 2022
Glaucoma Trial in London (Sildenafil 100mg)
Suspended
- Glaucoma
- Sildenafil 100mg
-
London, United KingdomWestern Eye Hospital
Jan 21, 2021
Pulmonary Hypertension, COPD Trial (Tadalafil)
Not yet recruiting
- Pulmonary Hypertension
- Chronic Obstructive Pulmonary Disease
- (no location specified)
Apr 25, 2023
Erectile Dysfunction Trial in Garches (Investigational product administration Xeomin® (MERZ PHARMACEUTICALS GMBH), Placebo
Recruiting
- Erectile Dysfunction
- Investigational product administration Xeomin® (MERZ PHARMACEUTICALS GMBH)
- Placebo administration
-
Garches, FranceNeuro-Urology-Andrology, Physical Medicine and Rehabilitation De
Mar 28, 2022
Erectile Dysfunction Trial in Banha (OnabotulinumtoxinA, Trimix)
Recruiting
- Erectile Dysfunction
- OnabotulinumtoxinA
- Trimix
-
Banha, Kalubiaya, EgyptBanha University Hospitals
Jan 6, 2022
Cystic Fibrosis Trial in Denver (sildenafil)
Completed
- Cystic Fibrosis
-
Denver, ColoradoNational Jewish Health
Oct 13, 2020
Raynaud Disease, Systemic Sclerosis, Digital Ulcer Trial in Seoul (Calcium Channel Blockers, Phosphodiesterase Inhibitors,
Terminated
- Raynaud Disease
- +2 more
- Calcium Channel Blockers
- +4 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Nov 8, 2020
Satisfaction With Phosphodiesterase 5 Inhibitors Treatment In
Completed
- Erectile Dysfunction
- (no location specified)
Jan 28, 2021
MDD Trial in Shibeen Elkom (Roflumilast 250Mcg Tab, Placebo)
Recruiting
- Major Depressive Disorder
- Roflumilast 500Mcg Tab
- Placebo
-
Shibeen Elkom, Menoufia, EgyptFaculty of Pharmacy
Jan 16, 2023
Low Cardiac Output Syndrome, Cardiogenic Shock, Acute Coronary Syndrome Trial in Ottawa (Milrinone, Dobutamine)
Completed
- Low Cardiac Output Syndrome
- +3 more
-
Ottawa, Ontario, CanadaUniversity of Ottawa Heart Institute
Jun 29, 2020
Pharmacologic Interaction Between ERAs and PDE-5 Inhibitors on
Completed
- Pulmonary Arterial Hypertension
- no intervention, only observation of different groups
-
Heidelberg, GermanyCentre for pulmonary hypertension, Thoraxclinic at the Universit
Jan 24, 2020
Right Heart Failure Trial in Roma (Pulmonary Vasodilators)
Recruiting
- Right Heart Failure
- Pulmonary Vasodilators
-
Roma, ItalySan Camillo Hospital
Apr 18, 2023
Pulmonary Arterial Hypertension Trial in Worldwide (Riociguat (Adempas, BAY63-2521), Sildenafil, Tadalafil)
Completed
- Pulmonary Arterial Hypertension
- Riociguat (Adempas, BAY63-2521)
- +2 more
-
Phoenix, Arizona
- +80 more
Feb 3, 2021
Sirolimus Eluting Balloon Utilization for Treatment of
Recruiting
- Erectile Dysfunction
- Endovascular procedure
-
Roma, Lazio, ItalyPoliclinico Tor Vergata
Dec 27, 2022
Healthy Volunteer Trial in Prahran (Drug: RT234 - vardenafil inhalation powder; Device: RS01 dry powder inhaler (RS01 DPI),
Completed
- Healthy Volunteer
- Drug: RT234 - vardenafil inhalation powder; Device: RS01 dry powder inhaler (RS01 DPI)
- Vardenafil Oral Tablet
-
Prahran, Victoria, AustraliaNucleus Network, Burnet Institute
Nov 2, 2022
Pseudohypoparathyroidism, Albright Hereditary Osteodystrophy, Pseudohypoparathyroidism Type 1a Trial in Nashville (Theophylline,
Recruiting
- Pseudohypoparathyroidism
- +2 more
- Theophylline
- Placebo
-
Nashville, TennesseeVanderbilt University Medical Center
Oct 4, 2022
Cystic Fibrosis Trial in Denver, Augusta (Sildenafil 40mg oral capsule, Placebo Oral capsule)
Recruiting
- Cystic Fibrosis
- Sildenafil 40mg oral capsule
- Placebo Oral capsule
-
Denver, Colorado
- +1 more
Aug 29, 2022
Pseudohypoparathyroidism, Albright Hereditary Osteodystrophy Trial in Nashville (Theophylline, Placebos)
Recruiting
- Pseudohypoparathyroidism
- Albright Hereditary Osteodystrophy
- Theophylline
- Placebos
-
Nashville, TennesseeAshley Shoemaker
Aug 15, 2022